These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8578824)

  • 21. Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis.
    Oberbeck R; Dahlweid M; Koch R; van Griensven M; Emmendörfer A; Tscherne H; Pape HC
    Crit Care Med; 2001 Feb; 29(2):380-4. PubMed ID: 11246320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
    Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants.
    Ichinohe T; Ainai A; Tashiro M; Sata T; Hasegawa H
    Vaccine; 2009 Oct; 27(45):6276-9. PubMed ID: 19840660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
    Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
    Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection.
    Lee G; Na YJ; Yang BG; Choi JP; Seo YB; Hong CP; Yun CH; Kim DH; Sohn EJ; Kim JH; Sung YC; Kim YK; Jang MH; Hwang I
    Plant Biotechnol J; 2015 Jan; 13(1):62-72. PubMed ID: 25065685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion.
    Keijzer C; Haijema BJ; Meijerhof T; Voorn P; de Haan A; Leenhouts K; van Roosmalen ML; van Eden W; Broere F
    Vaccine; 2014 May; 32(24):2904-10. PubMed ID: 24598720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Fang F; Zheng M; Chen Z
    Vaccine; 2010 Nov; 28(48):7690-8. PubMed ID: 20870054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates.
    Kim JR; Holbrook BC; Hayward SL; Blevins LK; Jorgensen MJ; Kock ND; De Paris K; D'Agostino RB; Aycock ST; Mizel SB; Parks GD; Alexander-Miller MA
    J Virol; 2015 Jul; 89(14):7291-303. PubMed ID: 25948746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe impairment of primary but not memory responses to influenza viral antigens in aged mice: costimulation in vivo partially reverses impaired primary immune responses.
    Sambhara S; Kurichh A; Miranda R; James O; Underdown B; Klein M; Tartaglia J; Burt D
    Cell Immunol; 2001 May; 210(1):1-4. PubMed ID: 11485346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.
    Asanuma H; Hirokawa K; Uchiyama M; Suzuki Y; Aizawa C; Kurata T; Sata T; Tamura S
    Vaccine; 2001 Jul; 19(28-29):3981-9. PubMed ID: 11427274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androstenediol-induced restoration of responsiveness to influenza vaccination in mice.
    Padgett DA; MacCallum RC; Loria RM; Sheridan JF
    J Gerontol A Biol Sci Med Sci; 2000 Sep; 55(9):B418-24. PubMed ID: 10995038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants.
    Benne CA; Harmsen M; van der Graaff W; Verheul AF; Snippe H; Kraaijeveld CA
    Vaccine; 1997 Jun; 15(9):1039-44. PubMed ID: 9261954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.
    Ji X; Ren Z; Xu N; Meng L; Yu Z; Feng N; Sang X; Li S; Li Y; Wang T; Zhao Y; Wang H; Zheng X; Jin H; Li N; Yang S; Cao J; Liu W; Gao Y; Xia X
    Viruses; 2016 Apr; 8(4):115. PubMed ID: 27110810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice.
    Russell RF; McDonald JU; Lambert L; Tregoning JS
    J Virol; 2016 May; 90(9):4735-4744. PubMed ID: 26912628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral and cell-mediated immune responses of old horses following recombinant canarypox virus vaccination and subsequent challenge infection.
    Adams AA; Sturgill TL; Breathnach CC; Chambers TM; Siger L; Minke JM; Horohov DW
    Vet Immunol Immunopathol; 2011 Feb; 139(2-4):128-40. PubMed ID: 21035197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(1):244-51. PubMed ID: 15802970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model.
    Hamouda T; Chepurnov A; Mank N; Knowlton J; Chepurnova T; Myc A; Sutcliffe J; Baker JR
    Hum Vaccin; 2010 Jul; 6(7):585-94. PubMed ID: 20421727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
    Kamlangdee A; Kingstad-Bakke B; Osorio JE
    J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single dose combination nanovaccine provides protection against influenza A virus in young and aged mice.
    Ross K; Senapati S; Alley J; Darling R; Goodman J; Jefferson M; Uz M; Guo B; Yoon KJ; Verhoeven D; Kohut M; Mallapragada S; Wannemuehler M; Narasimhan B
    Biomater Sci; 2019 Feb; 7(3):809-821. PubMed ID: 30663733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.